Cancer & Tumor MarkersNo Fasting RequiredTurnaround: 12–24 hours

CEA (Carcinoembryonic Antigen — Colorectal Tumor Marker)

Also known as: Carcinoembryonic Antigen, CEA Blood Test, Colon Cancer Tumor Marker, Colorectal CEA

Parameters Measured in the Report

A breakdown of individual biomarkers and biological reference intervals typically found in your report:

Biomarker	Standard Range	Unit	What It Means
Serum CEA (Carcinoembryonic Antigen)	Non-Smokers: < 3.0 Smokers: < 5.0 (Suspicious: > 5.0–10.0 Malignancy: > 10.0–20.0+)	ng/mL (or µg/L)	Oncofetal glycoprotein tumor marker; primary surveillance tool for colorectal carcinoma recurrence.

* Note: Reference ranges may vary slightly between testing instruments and reagent kits. Always refer to the reference interval printed on your specific pathology report.

Clinical Focus

Circulating concentration of oncofetal cell-surface glycoprotein involved in cellular adhesion, shed by gastrointestinal adenocarcinomas.

Sample & Specimen

Venous blood (Serum tube)

Fasting Protocol

No fasting required. Inform laboratory if you are a chronic cigarette smoker.

Turnaround Time

12–24 hours

What Is This Test?

Carcinoembryonic Antigen (CEA) is an oncofetal glycoprotein normally expressed during embryonic and fetal gastrointestinal development, with production largely shutting down after birth. In adult oncology, CEA is the premier clinical tumor marker for **Colorectal Adenocarcinoma**. When colorectal malignant cells proliferate, they shed significant quantities of CEA into the mesenteric circulation. Measuring baseline CEA before surgery establishes prognosis; serial CEA measurements every 3 months post-surgery is the most sensitive non-invasive method for detecting cancer recurrence (especially metastasis to the liver).

Why Did Your Doctor Order This Test?

Physicians routinely prescribe the CEA Test in the following clinical scenarios:

Baseline pre-operative staging and prognostic evaluation in patients diagnosed with colorectal carcinoma

Mandatory post-operative surveillance every 3 to 6 months for at least 5 years to detect early colorectal cancer recurrence

Monitoring clinical response during systemic chemotherapy or immunotherapy for metastatic gastrointestinal cancers

Diagnostic workup of suspected metastatic adenocarcinoma of unknown primary origin (GI, lung, breast, pancreatic)

How to Prepare Before Your Test

Fasting Requirement: No fasting required. Inform laboratory if you are a chronic cigarette smoker.

No fasting or special preparation required.
Cigarette smoking elevates baseline CEA — inform your physician of your smoking status so proper smoking-adjusted reference ranges are applied.

Understanding Your Results

What higher or lower readings generally mean in clinical practice:

If Values Are Higher Than Normal

Markedly elevated CEA (>10–20 ng/mL) in a patient with diagnosed colorectal cancer strongly correlates with advanced disease or distant metastasis (most commonly to the liver or peritoneum). A progressive, persistent rise in serial post-operative CEA levels warrants prompt PET-CT or contrast CT imaging to locate resectable recurrence.

If Values Are Lower Than Normal

Normal CEA (<3.0 ng/mL in non-smokers) is expected in healthy adults. However, a normal CEA does not completely rule out cancer recurrence, as some poorly differentiated colorectal tumors stop expressing the CEA glycoprotein.

Frequently Asked Questions

Can CEA be used to screen healthy people for colon cancer instead of a colonoscopy?

No. CEA is not a screening test for the general public. Many early-stage colon cancers do not elevate CEA at all, while non-cancerous conditions (smoking, gastritis, peptic ulcers, liver disease) cause mild elevations. Colonoscopy and stool occult blood (FIT) remain the gold standard for screening.

Why do smokers have higher normal CEA reference ranges?

Chronic cigarette smoke inhalation causes mild mucosal inflammation in the bronchial tree and gastrointestinal tract, stimulating benign epithelial cells to release small amounts of CEA (up to 5.0 ng/mL) into the blood.

Related Laboratory Tests

Tests frequently prescribed together or used as follow-up investigations:

Stool Routine & Occult Blood Examination (FOBT / R/M)

Microscopic presence of hidden (occult) hemoglobin, intestinal pus cells, red blood cells, ova, cysts, and parasites.

Liver Function Test (LFT / Hepatic Panel)

Bilirubin fractions, transaminases (ALT/SGPT, AST/SGOT), Alkaline Phosphatase (ALP), and proteins (Albumin, Globulin).

CA-125 (Cancer Antigen 125 — Ovarian Tumor Marker)

Circulating concentration of high-molecular-weight transmembrane glycoprotein antigen shed by coelomic and Müllerian epithelial tissues.

Alpha-Fetoprotein (AFP — Liver & Germ Cell Tumor Marker)

Circulating concentration of oncofetal plasma glycoprotein synthesized by fetal yolk sac and fetal hepatocytes.

Medical & Diagnostic Disclaimer

This guide is published for educational and patient informational purposes only. It is not a substitute for professional medical evaluation, diagnosis, or clinical advice.

A laboratory result that falls slightly outside standard statistical reference intervals does not automatically indicate disease; conversely, a normal result does not guarantee the absence of medical conditions. Only your attending physician can interpret lab findings in the context of your medical history, physical exam, and symptoms.